Flavio Luciano Ribichini
Latest contributions
PCI for complex calcific coronary artery disease - LIVE Case
22 May 2025 – From EuroPCR 2025
An 87-year-old female patient, at high bleeding risk and with preserved LV function, presented 2 months ago with an inferior STEMI and multivessel disease. She initially underwent RCA PCI followed by staged LCx PCI. She was now referred for PCI of a long, heavily calcified lesion...
Hypertension interventions in specific scenarios
22 May 2025 – From EuroPCR 2025
Explore interventions for hypertension in specific patient populations, including renal artery stenosis treatment and the role of renal denervation. Discuss multidisciplinary approaches and evidence supporting renal denervation in advanced kidney disease, heart failure, and young patients.
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Simplify PCI! Know where and how to win with drug-coated balloon
22 May 2025 – From EuroPCR 2025
This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...
Unconventional situations and complications during cardiovascular interventions
21 May 2025 – From EuroPCR 2025
Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award
21 May 2025 – From EuroPCR 2025
Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
How do I confidently expand my drug-coated balloon practice?
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...
Getting started with a renal denervation programme
20 May 2025 – From EuroPCR 2025
Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.
Ultrasound renal denervation is now guideline-recommended: how do I get started?
20 May 2025 – From EuroPCR 2025
Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and...
